To assess the benefits and harms of clevudine versus placebo, no intervention, or any of the nucleoside/nucleotide analogues, in people with chronic HBV infection.
This is a protocol.
To assess the benefits and harms of clevudine versus placebo, no intervention, or any of the nucleoside/nucleotide analogues, in people with chronic HBV infection.
This is a protocol.